Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESIST: Resistance Training vs Usual Care During Tirzepatide Treatment in Obesity
NCT07777575Phase 4Recruiting
- Sponsor
- Technical University of Munich
- Start
- Oct 2026
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
A Phase 4 trial of tirzepatide in obesity, sponsored by Technical University of Munich. Started Oct 2026; status: recruiting.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07777575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07777575.